BioClonetics Immunotherapeutics

Designing the first cure for HIV through the use of monoclonal antibodies

https://wefunder.com/bioclonetics

Total raised on Wefunder: 386766

Total investors: 586

Quick facts

• We have created a cell line that produces an anti-HIV antibody called Clone 3.
• We have demonstrated that Clone 3 neutralizes all clades and groups of HIV isolates.
• We have identified that Clone 3 targets HIV at an immutable site on the HIV virus.
• We expect to complete animal trials within 18 to 24 months.
• We are working with several world-class laboratories who will assist us in conducting the next steps of our plan.
• 1.2 million estimated people die from HIV each year.
• 2 million estimated people are infected with HIV each year.

Team profiles

• Gaurav Chandra